HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

In Brief

This article was originally published in The Rose Sheet

  • News

Executive Summary

IFRA Investigates Banned Ingredient Use

You may also be interested in...



In Brief

IFRA Announces Fifth Year Of 100% Compliance With Code Of Practice

The International Fragrance Association continues to face opposition from NGOs and misconceptions regarding fragrance safety despite five years of product testing showing its members to be 100% compliant with industry ingredient standards.

Could Unilever Investment In Microalgae Solve Firm's Palm Oil Problems?

Unilever is reasserting its commitment to environmental sustainability with an undisclosed investment in Solazyme, the same company that is helping the U.S. Navy to reach its renewable fuel goals

Table

View full table

Tags:
Latest Headlines

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories

‘Meaningful Revenues’ In 2023 Mark Strategic Milestone As Futura Looks To Future

See All
UsernamePublicRestriction

Register

RS017823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By